Stockreport

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Express Concern Regarding Report That Seres Allegedly Rebuffed an Outright Takeover Offer from Nestlé for $6.00 - $6.50 Per ShareRequest that the Board Immediately Provi [Read more]